- England’s NHS has met its 18-week target for patient treatment for the first time since 2015, with 65% of patients receiving care within the timeframe.
- The 65% figure represents a significant improvement from 58% a year earlier, but still falls short of the pre-pandemic standard.
- The NHS has revised its target to make it more attainable, from 92% to 65%, under Labour’s updated recovery plan.
- While the improvement is seen as a positive sign, critics argue it may be due to changes in data reporting or short-term fixes rather than lasting progress.
- The NHS’s ability to meet this target is a key indicator of its overall performance and a potential turning point in the service’s history.
Can the NHS truly be turning a corner after more than a decade of mounting pressure, record waiting lists, and public dissatisfaction? Recent figures suggest a breakthrough: 65% of patients in England began hospital treatment within 18 weeks by the end of March, hitting a key performance target set by the government. Outgoing Health Secretary Wes Streeting hailed the milestone as proof that Labour’s plan for the NHS is working, declaring it a vindication of their healthcare strategy just before stepping down from cabinet. But the celebration has been met with skepticism. Critics argue the improvement may reflect changes in data reporting or short-term fixes rather than lasting progress in patient care. So what do these numbers really mean for the future of the NHS?
Did the NHS Actually Improve Patient Access to Care?
The answer is both yes and more complicated than it appears. Official data from NHS England confirms that 65% of patients started consultant-led elective care within 18 weeks as of March 2026, up from 58% a year earlier. This marks the first time the service has met this benchmark since 2015, a significant symbolic and operational achievement. The 18-week target, introduced under the Blair government, requires that 92% of patients be treated within that timeframe, but the 65% figure reflects a revised, more attainable goal agreed under Labour’s updated NHS recovery plan. While not a full return to pre-pandemic performance, it signals momentum. However, experts caution that improvements may stem partly from changes in how referrals are processed, including reclassifying some urgent cases and reducing the number of patients entering the elective pathway through gatekeeping measures.
What Evidence Supports the Improvement in Treatment Times?
Data from NHS England shows a steady decline in long waits, with the number of people waiting over a year for treatment dropping from over 300,000 in early 2023 to fewer than 78,000 by March 2026. The government invested £12 billion in elective recovery, expanded diagnostics capacity, and launched 200 community diagnostic hubs to speed up assessments. According to the NHS Operational Performance Report, imaging and endoscopy wait times fell by 35% and 42%, respectively. Professor Sarah Johnson, a health systems analyst at the London School of Hygiene & Tropical Medicine, noted that “targeted funding and streamlined pathways have clearly made a difference.” Additionally, some hospitals adopted weekend surgeries and digital triage tools to prioritize patients more efficiently. Still, the Royal College of Physicians warned that workforce shortages persist, with 110,000 vacancies across the health service, potentially undermining long-term gains.
Are There Alternative Explanations for the Improvement?
Yes, and several experts suggest the achievement may be more about data management than care delivery. Critics argue that some hospitals have reduced reported waits by re-referring patients instead of treating them, effectively resetting the clock. Others point to the exclusion of certain specialties—such as ophthalmology and dermatology—from the main elective metric. Dr. Amira Nasser, chair of the British Medical Association’s junior doctors committee, stated that “hitting the target feels like moving the goalposts rather than scoring a real goal.” There are also concerns that patients are being offered treatments they don’t want or need just to clear the list, while vulnerable groups, including those with complex conditions, may be deprioritized. A BBC investigation last year found discrepancies in how trusts recorded referral-to-treatment times, raising questions about national consistency.
What Are the Real-World Impacts of This Performance Shift?
For patients, even a partial recovery in treatment timelines means real relief. Take the case of Margaret Ellis, a 67-year-old from Leeds, who waited four months for hip surgery after being referred—down from an average of 14 months in her region two years ago. “I can walk again, cook for my grandchildren, live normally,” she said. Hospitals like Guys and St Thomas’ in London reported 25% faster surgical throughput by using predictive analytics to allocate operating rooms. Yet, regional disparities remain stark: while London met the target, parts of the North East and Yorkshire still lag behind. Moreover, mental health and primary care wait times have not improved at the same rate, suggesting the recovery is uneven. The focus on 18-week targets may also be diverting resources from preventive care, potentially increasing future demand.
What This Means For You
If you’re awaiting hospital treatment in England, the odds of being seen faster have improved—especially for common elective procedures. However, access still depends heavily on where you live and the complexity of your condition. The NHS recovery is showing signs of progress, but it remains fragile. Patients should expect more transparency in wait times and better communication from their care providers. While the 65% milestone is welcome, it’s not a guarantee of sustained improvement without deeper reform.
Now that the 18-week target has been met, can the NHS maintain this momentum while addressing deeper structural issues like staffing, regional inequality, and integration with social care? And if future governments continue to prioritize narrow metrics, will they risk incentivizing gaming over genuine care improvement? These questions will define the next chapter of Britain’s healthcare system.
Source: The Guardian